Oleg Nodelman

Founder and Portfolio Manager of EcoR1 Capital LLC

Oleg Nodelman is the Founder and Portfolio Manager of EcoR1 Capital LLC, a biotech-focused investment advisory firm established in 2013, which invests in companies at all stages of research and development. With more than 20 years of experience in biotech investing, Mr. Nodelman has expertise in all aspects of investment management and deep roots in the biotech and scientific communities. He currently also serves as a Board Member for two other publicly traded companies: Galapagos (Euronext & NASDAQ: GLPG), a clinical-stage biotechnology company focused on small molecules, CAR-T therapies, and biologics in oncology and immunology, and Zymeworks (NASDAQ: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the standard of care for difficult-to-treat diseases, including cancer, inflammation, and autoimmune disease. Mr. Nodelman has a Bachelor of Science in Foreign Service with a concentration in Science and Technology from Georgetown University.